Viatris commences tender offer to acquire Pacira BioSciences
Viatris has commenced a tender offer through a wholly-owned subsidiary to acquire all outstanding shares of Pacira BioSciences, per a PRNewswire release. The formal launch moves the deal from proposal to execution phase for the specialty pain therapeutics maker.
Source:
prnewswire.com: https://www.prnewswire.com/news-releases/viatris-announces-commencement-of-tender-offer-to-acquire-pacira-biosciences-inc-302924916.html
Not financial advice. For informational and educational purposes only.
Video explainer: Intel just posted its best data center growth in 15 years and the stock still fell about 25% before the open 📉
Intel just posted its best data center growth in 15 years and the stock still fell about 25% before the open 📉 Q3 revenue $16.5B (up 21%) and adjusted EPS 52…
The number that matters in CXMT's quarter is 19.3%, the sequential growth.
The number that matters in CXMT's quarter is 19.3%, the sequential growth. Everyone is quoting 613% year over year, but quarter on quarter China's memory champ grew far more modestly, which makes the cheap-Chinese-supply panic look like a convenient story for a selloff that has more than one driver.
If Bloomberg's report holds, Marvell would be paying for optics with its own stock.
If Bloomberg's report holds, Marvell would be paying for optics with its own stock. The market's first reaction fits my usual read on deals: they tend to favor the company being bought more than the buyer. Bloomberg reported on October 28, citing unnamed sources, that Marvell is…
Rates Hold Near 5%
The 10-year Treasury yield closed at 4.98%, up 2 basis points over the week, with long-end yields moving several times as much as bill yields.
The 10-Year Treasury yield closed at 4.98% in the latest session, up 2 basis points over the week. That small net change hides a wider swing: the 10-year sat at 5.13% in the prior week before dropping to 4.96%, then traded back up to 5.05% before settling…